Yasuhito Sasaki, Shonankamakura General Hospital, Japan
The purpose of this historical review is to trace the application of radiopharmaceuticals for diagnosis of tumors and treatment of cancer in the past half a century in Japan. Positron Emission Tomography?PET?using 18F labelled fluorodeoxyglucose (a radioactive glucose analog) has [....] » Read More
Title : Genomic instability analysis in DNA from papanicolaou test provides a new avenue for early diagnosis of high-grade serous ovarian cancer
Sergio Marchini, Humanitas Research Hospital, Italy
Epithelial ovarian cancer (EOC) is the 5th cancer-related cause of death among women worldwide. EOC is usually diagnosed at an advanced stage when tumour cells have already spread throughout the pelvis in the peritoneal cavity. Five-year survival rate is around 30% in patients wi [....] » Read More
Title : Micro-Invasive solid papillary carcinoma of the nipple: A case study
Shinya Tajima, NHO. Shizuoka Medical Centre, Japan
Herein, we would like to present the case of about 80-year-old female. Her chief complaint was bloody nipple discharge in the left breast. She came to our hospital for thorough examination and treatment. Ultrasonography detected intraductal carcinoma of about 10mm spreading. The [....] » Read More
Title : Multiple endocrine neoplasia and sporadic insulinomas
Klaus Brusgaard, Odense University Hospital, Denmark
Functional pancreatic neuroendocrine tumors (PNETs) may be hereditary or sporadic. Hereditary forms are often caused by MEN1 mutations. The majority of insulinomas are sporadic, solitary and low-grade. The tumorigenesis in sporadic insulinomas is not well described. We describe t [....] » Read More
Title : Multiplexed detection of biomarkers for early-stage ovarian cancer
Michael Thompson, University of Toronto, Canada
Ovarian cancer(OC) results in some 150,000 deaths worldwide of nearly 300,000 new cases each year. Unfortunately, only 20% of patients are diagnosed at the early stages (I and II) of the disease when treatment is most effective, leading to a 5-year relative survival rate of only [....] » Read More
Title : MYC expression is an adverse prognostic factor ALK+ anaplastic large cell lymphoma
Jie Xu, The University of Texas MD Anderson Cancer Center, United States
The role of MYC dysregulation has been studied extensively in B cell lymphomas, but little is known about its significance in T cell lymphomas. This study, for the first time in the literature, assessed the clinicopathologic and prognostic significance of MYC expression in [....] » Read More
Title : ColoNode analysis of colorectal cancer lymph nodes - An improved method for assessment of tumor stage and prognosis
Marie Louise Hammarstrom, Umea University, Sweden
Colorectal cancer is globally one of the most prevalent cancers and a common cause of cancer-related mortality. The curative treatment is surgery. Unfortunately, recurrence is common with approximately 25% of the patients having relapse. Lymph node (LN) metastasis is the single m [....] » Read More
Title : Genomic analyses of circulating cell free DNA in follicular lymphoma: Diagnostic prognostic and therapeutic implications
Can Kucuk , Dokuz Eylul University, Turkey
In this talk, the potential of cfDNA genotyping on diagnosis and prognostication of follicular lymphoma (FL) will be presented. As a frequent non-Hodgkin lymphoma type, FL is generally indolent with a variable clinic presentation including asymptomatic as well as symptomati [....] » Read More
Title : Innate lymphoid cells and cancer: A new frontier in immunology
Giuseppe Ercolano, University of Naples Federico II, Italy
Innate lymphoid cells (ILCs) have emerged as pivotal players in the immune system, with their roles extending far beyond traditional innate immunity. Recent advances in immunology have highlighted the significant influence of ILCs on tumor development, progression, and response t [....] » Read More
Title : Towards a home companion diagnostic test for the early detection of breast cancer
Nur Aimi Aliah Zainurin, Aberystwyth University, United Kingdom
Breast cancer is one of the deadliest cancers with 685,000 deaths and 2.26 million cases reported in 2020. Early detection is crucial for better treatment outcome. Mammography is the gold standard screening modality for breast cancer diagnosis but use of a cost-effective companio [....] » Read More
Title : Proposal for new diagnostic criteria for sarcopenia based on CT Imaging in Saudi population: A novel method in oncology research
Zahra Husain, Eastern Health Cluster, Saudi Arabia
Background: Sarcopenia has been shown to be an independent predictor of lower overall survival in oncology patients. Several studies have used computed tomography (CT) to measure psoas muscle surface area to define sarcopenia. However, the cut-off values based on CT imaging remai [....] » Read More
Title : New paradigm shift towards pancreatic cancer enabling nano- based biosensors for detection of exosomes
Tanvi Gupta, National Cheng Kung University, Taiwan
Pancreatic cancer shows high mortality rate with poor prognosis and is expected to be the major cause of cancer deaths by 2030. Due to its aggressive nature for growth and progression, it usually goes unnoticed at an early stage due to lack of symptoms and by the time diagnosis a [....] » Read More
Title : Melanoma with brain metastasis
Maria Zahra, Cardiff and Vale NHS trust hospital, United Kingdom
Melanoma metastasis to brain. A case related to the presentation of a patient who presented with seizures and CT head revealed space occupying lesion. This patient had a background of Melanoma for which he had a biopsy done and he was waiting the results. Audience Take Away No [....] » Read More
Title : Introducing CancerHubs: A systematic data mining and elaboration approach for identifying novel cancer related protein interaction hubs
Nicola Manfrini, University of Milan, Italy
Introduction: Discovering the players and understanding the molecular mechanisms involved in cancer initiation and progression are fundamental issues for developing effective diagnostic tools and targeted therapies. Traditional methods for predicting protein involvement in cancer [....] » Read More
Title : Implementation of Enhanced Recovery After Surgery (ERAS) protocols in cancer surgery: A case report
Amrita Anand Dhar, Leicester Royal Infirmary, United Kingdom
Introduction: Enhanced Recovery After Surgery (ERAS) protocols represent a paradigm shift in perioperative care, focusing on evidence-based practices to reduce surgical stress, optimize pain management, and accelerate postoperative recovery. Initially developed for colorectal sur [....] » Read More
Title : Vacuum assisted breast biopsy: What can we do during an active bleeding and vasovagal syncope in order to complete the procedure?
Ivelis M Sarachi, Centro Diagnostico Mon, Argentina
Vacuum Assisted Breast Biopsy (VABB) is a minimally invasive procedure in which a suspicious breast sample (BS) is removed with a vacuum pump through a small skin incision under local anesthesia. Can be performed under mammography (M), US or MRI guidance. Our topic is the VABB M [....] » Read More
Title : Noninvasive nondestructive comparison of pigmented and nonpigmented melanomas using vibrational optical coherence tomography
Frederick H Silver, Robert Wood Johnson Medical School, Rutgers University, United States
We have developed a new noninvasive technique termed vibrational optical coherence tomography (VOCT) to optically image and measure the resonant frequency of cellular, blood vessel, papillary collagen, and fibrotic tissue in the skin. Preliminary results on normal skin indicate t [....] » Read More
Title : Targeted immunotherapy to inhibit circadian-disruption induced aggressive tumorigenesis
Tapasree Roy Sarkar, Texas A&M University, United States
Background: Epidemiological studies have shown that circadian rhythm disruption (CRD) is associated with the risk of breast cancer. However, the role of CRD in mammary gland morphology and aggressive basal mammary tumorigenesis and the molecular mechanisms underlying CRD and canc [....] » Read More
Title : ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE
Romi Gupta, The University of Alabama at Birmingham, United States
Ovarian cancer is a complex disease associated with multiple genetic and epigenetic alterations. The emergence of treatment resistance in most patients causes ovarian cancer to become incurable, and novel therapies remain necessary. We identified epigenetic regulator ATPase famil [....] » Read More
Title : An attention based network for improved glioma grading
Sreedevi Gutta, California State University San Marcos, United States
Accurate prediction of glioma grade is significant for treatment planning and management. Prior studies require a segmentation network to extract the tumor region, which was then used by classification network for grade prediction. However, tumor segmentation was a challenging pr [....] » Read More
Title : Cancer: An overview
Harris Phillip, NHS, United Kingdom
In this presentation, I will explore the growth of cancer treatment and recognise some of our failures. I will lament that despite the strides made we are unable to find a cure. We will reflect on the papyrus papers in which is a description of the way cancer can be treated but a [....] » Read More